US 11718621
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted A61KA61K45/06A61P
Quick answer
US patent 11718621 (Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use) held by SPERO THERAPEUTICS, INC. expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SPERO THERAPEUTICS, INC.
- Grant date
- Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K45/06, A61P, A61P31/04